Dr Mark Morris leads a research group within the Research Institute In Healthcare Science (RHIS) investigating the molecular biology and genetics of cancer development.
Mark gained his PhD in 2001 following a period of research (at the University of Wales College of Medicine) into the regulation of proliferative life-span barriers in human tumours.
Prior to joining the University of Wolverhampton, in 2010, Mark investigated the molecular basis of cancer and developmental diseases with a particulate interest in epigenetic gene dysregulation as a mechanism that drives tumour formation. This research was carried out at the Department of Medical Genetics, University of Birmingham, where he currently holds the post of Honorary Lecturer in Molecular Oncology. His teaching includes general biochemistry, cell biology, and molecular genetics, particularly related to human disease.
Mark is currently investigating:
Urological Oncology 2nd edition 2014
Chapter 3: Genetics and Genito-Urinary Cancer
Eds: Nargund, Vinod H.; Raghavan, Derek; Sandler, Howard M.
If you are interesting in studying any of these subject areas at doctoral level please contact Mark on the contact details above.